Absorptive capacity, coauthoring behavior, and the organization of research in drug discovery

Journal of Industrial Economics

Volumn 46, Issue 2, 1998, Pages 157-182

  Cockburn, Iain M ^a   Henderson, Rebecca M ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032388957     PISSN: 00221821     EISSN: None     Source Type: Journal    
DOI: 10.1111/1467-6451.00067     Document Type: Article

References (30)

1. Aoki, M., 1990, 'Towards An Economic Model of the Japanese firm', Journal of Economic Literature, 28(1), pp. 1-27.
2. Cockburn, I. and Henderson, R., 1994, 'Racing to Invest? The Dynamics of Competition in Ethical Drug Discovery', Journal of Economics and Management Strategy, 3(3), pp. 481-519.
3. Cockburn, I. and Henderson, R., 1996, 'Exploring Inertia: Complementarities and Firm Effects in Pharmaceutical Research', Mimeo, MIT April 1996.
4. Cohen, W. M. and Levinthal, D. A., 1989, 'Innovation and Learning: The Two Faces of R&D', Economic Journal, 99, pp. 569-596.
5. Cohen, L. and Noll, R., 1996, 'Privatizing Public Research: the New Competitiveness Strategy' in Landau, R., Taylor, T. and Wright, G., (eds.) The Mosaic of Economic Growth (Stanford University Press, Stanford).
6. Comroe, J. and Dripps, R., 1976, 'Scientific Basis for the Support of Biomedical Research', Science, 192, p. 105.
7. Gambardella, A., 1992, 'Competitive Advantage from in-house scientific research: The US pharmaceutical industry in the 1980s', Research Policy, XX, pp. 1-17.
8. Gambardella, A., 1995, Science and Innovation: the US Pharmaceutical Industry in the 1980s (Cambridge University Press, Cambridge).
9. Griliches, Z., 1979, 'Issues in Assessing the Contribution of Research and Development to Productivity Growth', Bell Journal of Economics, 10(1), pp. 92-116.
10. Griliches, Z., 1994, 'Productivity, R&D and the Data Constraint', American Economic Review, 84(1), pp. 1-23.
11. Henderson, R. and Cockburn, I., 1994, 'Measuring Competence? Exploring Firm Effects in Pharmaceutical Research', Strategic Management Journal, 15, pp. 63-84.
12. Henderson, R. and Cockburn, I., 1996, 'Scale, Scope and Spillovers: The Determinants of Research Productivity in Drug Discovery', RAND Journal of Economics, 27(1), pp. 32-59.
13. Hicks, D., 1995, 'Published Papers, Tacit Competencies and Corporate Management of the Public/Private Character of Knowledge', Industrial and Corporate Change, 4(2), pp. 401-424.
14. Jones, C. and Williams, J., 1995, 'Too Much of a Good Thing? The Economics of Investment in R&D' Stanford University Department of Economics Working Paper #96-005.
15. Koenig, E., 1982, 'A Bibliometric Analysis of Pharmaceutical Research', Research Policy, 12(1), pp. 15-36.
16. Liebskind, J. P., Oliver, A. L., Zucker, L. and Brewer, M., 1995, 'Social Networks, Learning, and Flexibility: Sourcing Scientific Knowledge in New Biotechnology Firms', NBER Working Paper No. 5320, November 1995.
17. Maxwell, R. A. and Eckhardt, S. B., 1990, Drug Discovery: A Case Book and Analysis (Humana Press, Clifton NJ).
18. Narin, F. and Olivastro, D., 1992, 'Status Report - Linkage Between Technology and Science', Research Policy, 21(3), pp. 237-249.
19. Nelson, R., 1988, 'Institutions Supporting Technical Change in the United States', in Dosi, G. et al. (eds.), Technological Change and Economic Theory (Pinter, London).
20. Nelson, R., 1990, 'Capitalism as an Engine of Progress', Research Policy, 19(3), pp. 193-214.
21. Penan, H., 1996, 'R&D Strategy in a Techno-economic network: Alzheimer's disease therapeutic strategies', Research Policy, 25, pp. 337-358.
22. Raiten, D. and Berman, S., 1993, 'Can the Impact of Basic Biomedical Research be Measured? A Case Study Approach'. Working Paper, Life Sciences Research Office Federation of American Societies for Experimental Biology.
23. Rosenberg, N. and Nelson, R., 1993, 'American Universities and Technical Advance in Industry', CEPR Working Paper #342, Stanford University.
24. Stephan, P., 1996, 'An Essay on the Economics of Science', Journal of Economic Literature, 34(3), pp. 1191-1235.
25. Ward, M. and Dranove, D., 1995, 'The Vertical Chain of R&D in the Pharmaceutical Industry'. Economic Inquiry, 33, pp. 1-18.
26. Walsh, V., 1984, 'Invention and Innovation in the Chemical Industry: Demand-pull or Discovery-push?', Research Policy, 13, pp. 211-234.
27. Wurtman, R. J. and Bettiker, R. L., 1994, 'How to Find a Treatment for Alzheimer's Disease', Neurobiology of Aging, 15, pp. S1-S3.
28. Zucker, L., Darby, M. and Brewer, M., 1997, 'Intellectual Capital and The Birth of U.S. Biotechnology Enterprises', NBER Working Paper No. 4653, February 1994.
29. Zucker, L., Darby, M. and Armstrong, J., 1994, 'Intellectual Capital and the Firm: the Technology of Geographically Localized Knowledge Spillovers', NBER Working Paper No. 4946, December 1994.
30. Zucker, L. and Darby, M., 1995, 'Virtuous Circles of Productivity: Star Bioscientists and the Institutional Transformation of Industry', NBER Working Paper No. 5342, November 1995.